150 related articles for article (PubMed ID: 31205531)
1. Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer.
Li S; Yin L; Huang K; Zhao Y; Zhang H; Cai C; Xu Y; Huang L; Wang X; Lan T; Li H; Ma P
J Cancer; 2019; 10(7):1755-1763. PubMed ID: 31205531
[No Abstract] [Full Text] [Related]
2. Downregulation of EphA5 by promoter methylation in human prostate cancer.
Li S; Zhu Y; Ma C; Qiu Z; Zhang X; Kang Z; Wu Z; Wang H; Xu X; Zhang H; Ren G; Tang J; Li X; Guan M
BMC Cancer; 2015 Jan; 15():18. PubMed ID: 25609195
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of DACT-2 methylation in serum of prostate cancer patients.
Lan T; Yin L; Zhang H; Gu B; Ma P; Li S; Li H
Ann Palliat Med; 2021 Mar; 10(3):2421-2428. PubMed ID: 33440955
[TBL] [Abstract][Full Text] [Related]
5. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer.
Vatanmakanian M; Steffan JJ; Koul S; Ochoa AC; Chaturvedi LS; Koul HK
Front Endocrinol (Lausanne); 2023; 14():1156120. PubMed ID: 37900138
[TBL] [Abstract][Full Text] [Related]
6. Promoter Gene Methylation Regulates Clooxygenase-2 Expression in Androgen-Dependent and Independent Prostate Cancer Cells.
Liu CY; Su SH; Chang TH; Hsieh ML; Chang YH; Pang JS; Chuang CK
World J Oncol; 2022 Jun; 13(3):107-116. PubMed ID: 35837323
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
[TBL] [Abstract][Full Text] [Related]
8. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer.
Li S; Wu Z; Chen Y; Kang Z; Wang H; He P; Zhang X; Hu T; Zhang Q; Cai Y; Xu X; Guan M
Tumour Biol; 2016 Apr; 37(4):5365-74. PubMed ID: 26561474
[TBL] [Abstract][Full Text] [Related]
10. Regulation of
Yang X; Wang S; Reheman A
Cancer Manag Res; 2020; 12():6411-6420. PubMed ID: 32801881
[TBL] [Abstract][Full Text] [Related]
11. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features.
Guan M; Xu C; Zhang F; Ye C
Int J Cancer; 2009 Jan; 124(1):88-94. PubMed ID: 18821581
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
[TBL] [Abstract][Full Text] [Related]
15. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
16. CCAAT enhancer binding protein β promotes tumor growth and inhibits apoptosis in prostate cancer by methylating estrogen receptor β.
Li D; Liu J; Huang S; Bi X; Wang B; Chen Q; Chen H; Pu X
Neoplasma; 2018; 65(1):34-41. PubMed ID: 29322786
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways.
Zhou H; Wu G; Ma X; Xiao J; Yu G; Yang C; Xu N; Zhang B; Zhou J; Ye Z; Wang Z
J Exp Clin Cancer Res; 2018 Apr; 37(1):89. PubMed ID: 29699590
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma.
Dansranjavin T; Wagenlehner F; Gattenloehner S; Steger K; Weidner W; Dammann R; Schagdarsurengin U
Prostate; 2012 Oct; 72(14):1550-8. PubMed ID: 22415519
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
